Camber Pharma Launches Generic Canasa® Suppositories
Piscataway, NJ, August 5, 2020– Camber Pharmaceuticals is pleased to announce that it has launched Mesalamine suppositories, which is the generic version of Canasa® suppositories. Mesalamine suppositories is used to treat mild to moderate ulcerative colitis.
Mesalamine Suppositories are available from Camber in 1000mg- 30ct blister pack.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






